150 related articles for article (PubMed ID: 33165863)
21. Clonal reversal of ageing-associated stem cell lineage bias via a pluripotent intermediate.
Wahlestedt M; Erlandsson E; Kristiansen T; Lu R; Brakebusch C; Weissman IL; Yuan J; Martin-Gonzalez J; Bryder D
Nat Commun; 2017 Feb; 8():14533. PubMed ID: 28224997
[TBL] [Abstract][Full Text] [Related]
22. Human Adipose-Derived Pericytes: Biological Characterization and Reprogramming into Induced Pluripotent Stem Cells.
Ahmed TA; Shousha WG; Abdo SM; Mohamed IK; El-Badri N
Cell Physiol Biochem; 2020 Apr; 54(2):271-286. PubMed ID: 32233339
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA Regulation Along the Course of Cellular Reprogramming to Pluripotency.
Ishtiaq M; Waseem M; Mehmood R
Curr Mol Med; 2018; 18(1):58-64. PubMed ID: 29663886
[TBL] [Abstract][Full Text] [Related]
24. Experimental limitations using reprogrammed cells for hematopoietic differentiation.
Seiler K; Tsuneto M; Melchers F
J Biomed Biotechnol; 2011; 2011():895086. PubMed ID: 22187531
[TBL] [Abstract][Full Text] [Related]
25. Reprogramming somatic cells into pluripotent stem cells using miRNAs.
Anokye-Danso F
Methods Mol Biol; 2014; 1150():273-81. PubMed ID: 24744006
[TBL] [Abstract][Full Text] [Related]
26. Reprogramming Methods Do Not Affect Gene Expression Profile of Human Induced Pluripotent Stem Cells.
Trevisan M; Desole G; Costanzi G; Lavezzo E; Palù G; Barzon L
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28117672
[TBL] [Abstract][Full Text] [Related]
27. Adult stem and progenitor cells.
Geraerts M; Verfaillie CM
Adv Biochem Eng Biotechnol; 2009; 114():1-21. PubMed ID: 19373451
[TBL] [Abstract][Full Text] [Related]
28. Reprogramming of Human Fibroblasts to Induced Pluripotent Stem Cells with Sleeping Beauty Transposon-Based Stable Gene Delivery.
Sebe A; Ivics Z
Methods Mol Biol; 2016; 1400():419-27. PubMed ID: 26895068
[TBL] [Abstract][Full Text] [Related]
29. mRNA Reprogramming of T8993G Leigh's Syndrome Fibroblast Cells to Create Induced Pluripotent Stem Cell Models for Mitochondrial Disorders.
Grace HE; Galdun P; Lesnefsky EJ; West FD; Iyer S
Stem Cells Dev; 2019 Jul; 28(13):846-859. PubMed ID: 31017045
[TBL] [Abstract][Full Text] [Related]
30. Cellular Reprogramming Allows Generation of Autologous Hematopoietic Progenitors From AML Patients That Are Devoid of Patient-Specific Genomic Aberrations.
Salci KR; Lee JH; Laronde S; Dingwall S; Kushwah R; Fiebig-Comyn A; Leber B; Foley R; Dal Cin A; Bhatia M
Stem Cells; 2015 Jun; 33(6):1839-49. PubMed ID: 25764124
[TBL] [Abstract][Full Text] [Related]
31. The piggyBac Transposon as a Platform Technology for Somatic Cell Reprogramming Studies in Mouse.
Woltjen K; Kim SI; Nagy A
Methods Mol Biol; 2016; 1357():1-22. PubMed ID: 26126450
[TBL] [Abstract][Full Text] [Related]
32. Concise review: programming human pluripotent stem cells into blood.
Easterbrook J; Fidanza A; Forrester LM
Br J Haematol; 2016 Jun; 173(5):671-9. PubMed ID: 26996518
[TBL] [Abstract][Full Text] [Related]
33. Generation of iPSCs from genetically corrected Brca2 hypomorphic cells: implications in cell reprogramming and stem cell therapy.
Navarro S; Moleiro V; Molina-Estevez FJ; Lozano ML; Chinchon R; Almarza E; Quintana-Bustamante O; Mostoslavsky G; Maetzig T; Galla M; Heinz N; Schiedlmeier B; Torres Y; Modlich U; Samper E; Río P; Segovia JC; Raya A; Güenechea G; Izpisua-Belmonte JC; Bueren JA
Stem Cells; 2014 Feb; 32(2):436-46. PubMed ID: 24420904
[TBL] [Abstract][Full Text] [Related]
34. Strategies to generate induced pluripotent stem cells.
Hayes M; Zavazava N
Methods Mol Biol; 2013; 1029():77-92. PubMed ID: 23756943
[TBL] [Abstract][Full Text] [Related]
35. Re-entering the pluripotent state from blood lineage: promises and pitfalls of blood reprogramming.
Chen Y; Yi Y; Xu J; Chan WK; Loh YH
FEBS Lett; 2019 Dec; 593(23):3244-3252. PubMed ID: 31691960
[TBL] [Abstract][Full Text] [Related]
36. Generation of Hematopoietic-Like Stem Cells from Adult Human Peripheral Blood Following Treatment with Platelet-Derived Mitochondria.
Yu H; Hu W; Song X; Descalzi-Montoya D; Yang Z; Korngold R; Zhao Y
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32549211
[TBL] [Abstract][Full Text] [Related]
37. Human Cortical Neuron Generation Using Cell Reprogramming: A Review of Recent Advances.
McCaughey-Chapman A; Connor B
Stem Cells Dev; 2018 Dec; 27(24):1674-1692. PubMed ID: 30343634
[TBL] [Abstract][Full Text] [Related]
38. Derivation of Skeletal Myogenic Precursors from Human Pluripotent Stem Cells Using Conditional Expression of PAX7.
Darabi R; Perlingeiro RC
Methods Mol Biol; 2016; 1357():423-39. PubMed ID: 25403466
[TBL] [Abstract][Full Text] [Related]
39. Generation and characterization of human iPSC line MML-6838-Cl2 from mobilized peripheral blood derived megakaryoblasts.
Hansen M; Varga E; Wüst T; Brouwer N; Beauchemin H; Mellink C; van der Kevie-Kersemaekers AM; Möröy T; van der Reijden B; von Lindern M; van den Akker E
Stem Cell Res; 2017 Jan; 18():26-28. PubMed ID: 28395797
[TBL] [Abstract][Full Text] [Related]
40. Stiffness of Hydrogels Regulates Cellular Reprogramming Efficiency Through Mesenchymal-to-Epithelial Transition and Stemness Markers.
Choi B; Park KS; Kim JH; Ko KW; Kim JS; Han DK; Lee SH
Macromol Biosci; 2016 Feb; 16(2):199-206. PubMed ID: 26439948
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
